vs
Side-by-side financial comparison of Nuvation Bio Inc. (NUVB) and REGIS CORP (RGS). Click either name above to swap in a different company.
REGIS CORP is the larger business by last-quarter revenue ($57.1M vs $41.9M, roughly 1.4× Nuvation Bio Inc.). On growth, Nuvation Bio Inc. posted the faster year-over-year revenue change (633.1% vs 22.3%).
Nuvation Bio Inc. is a clinical-stage biopharmaceutical company focused on researching and developing targeted oncology therapies to address unmet medical needs in difficult-to-treat cancer types. Its core pipeline features novel drug candidates targeting key oncogenic pathways, with primary operations and market presence centered in North America.
REGIS CORPRGSEarnings & Financial Report
Regis Corporation is an American operator of hair salons. As of August 2021, it has 5,563 franchised and 276 company-owned salons. Its headquarters are in Minneapolis, Minnesota.
NUVB vs RGS — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $41.9M | $57.1M |
| Net Profit | — | $456.0K |
| Gross Margin | — | — |
| Operating Margin | -81.3% | 10.8% |
| Net Margin | — | 0.8% |
| Revenue YoY | 633.1% | 22.3% |
| Net Profit YoY | — | -94.0% |
| EPS (diluted) | $-0.11 | $0.16 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $41.9M | $57.1M | ||
| Q3 25 | $13.1M | $59.0M | ||
| Q2 25 | — | $60.4M | ||
| Q1 25 | — | $57.0M | ||
| Q4 24 | $5.7M | $46.7M | ||
| Q3 24 | — | $46.1M | ||
| Q2 24 | — | $49.4M | ||
| Q1 24 | $0 | $49.2M |
| Q4 25 | — | $456.0K | ||
| Q3 25 | $-55.8M | $1.4M | ||
| Q2 25 | — | $116.5M | ||
| Q1 25 | — | $250.0K | ||
| Q4 24 | — | $7.6M | ||
| Q3 24 | — | $-853.0K | ||
| Q2 24 | — | $91.2M | ||
| Q1 24 | $-14.8M | $-2.3M |
| Q4 25 | — | — | ||
| Q3 25 | 74.5% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 26.2% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -81.3% | 10.8% | ||
| Q3 25 | -430.1% | 10.0% | ||
| Q2 25 | — | 12.1% | ||
| Q1 25 | — | 8.8% | ||
| Q4 24 | -944.5% | 11.8% | ||
| Q3 24 | — | 4.6% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 8.3% |
| Q4 25 | — | 0.8% | ||
| Q3 25 | -425.2% | 2.3% | ||
| Q2 25 | — | 192.9% | ||
| Q1 25 | — | 0.4% | ||
| Q4 24 | — | 16.4% | ||
| Q3 24 | — | -1.9% | ||
| Q2 24 | — | 184.7% | ||
| Q1 24 | — | -4.7% |
| Q4 25 | $-0.11 | $0.16 | ||
| Q3 25 | $-0.16 | $0.49 | ||
| Q2 25 | — | $43.67 | ||
| Q1 25 | — | $0.08 | ||
| Q4 24 | $0.00 | $2.71 | ||
| Q3 24 | — | $-0.36 | ||
| Q2 24 | — | $38.40 | ||
| Q1 24 | $-0.07 | $-1.00 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $529.2M | $18.4M |
| Total DebtLower is stronger | $47.2M | $113.3M |
| Stockholders' EquityBook value | $305.7M | $188.7M |
| Total Assets | $594.8M | $588.3M |
| Debt / EquityLower = less leverage | 0.15× | 0.60× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $529.2M | $18.4M | ||
| Q3 25 | $549.0M | $16.6M | ||
| Q2 25 | — | $17.0M | ||
| Q1 25 | — | $13.3M | ||
| Q4 24 | $502.7M | $10.2M | ||
| Q3 24 | — | $6.3M | ||
| Q2 24 | — | $10.1M | ||
| Q1 24 | $597.0M | $5.9M |
| Q4 25 | $47.2M | $113.3M | ||
| Q3 25 | $47.1M | $111.3M | ||
| Q2 25 | — | $110.8M | ||
| Q1 25 | — | $112.0M | ||
| Q4 24 | — | $111.5M | ||
| Q3 24 | — | $95.2M | ||
| Q2 24 | — | $99.5M | ||
| Q1 24 | — | $179.7M |
| Q4 25 | $305.7M | $188.7M | ||
| Q3 25 | $325.9M | $187.6M | ||
| Q2 25 | — | $185.6M | ||
| Q1 25 | — | $68.6M | ||
| Q4 24 | $463.8M | $66.7M | ||
| Q3 24 | — | $56.4M | ||
| Q2 24 | — | $56.8M | ||
| Q1 24 | $594.0M | $-35.8M |
| Q4 25 | $594.8M | $588.3M | ||
| Q3 25 | $601.6M | $592.1M | ||
| Q2 25 | — | $599.0M | ||
| Q1 25 | — | $511.2M | ||
| Q4 24 | $540.6M | $530.1M | ||
| Q3 24 | — | $508.9M | ||
| Q2 24 | — | $530.5M | ||
| Q1 24 | $613.1M | $543.7M |
| Q4 25 | 0.15× | 0.60× | ||
| Q3 25 | 0.14× | 0.59× | ||
| Q2 25 | — | 0.60× | ||
| Q1 25 | — | 1.63× | ||
| Q4 24 | — | 1.67× | ||
| Q3 24 | — | 1.69× | ||
| Q2 24 | — | 1.75× | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-29.7M | $1.7M |
| Free Cash FlowOCF − Capex | — | $891.0K |
| FCF MarginFCF / Revenue | — | 1.6% |
| Capex IntensityCapex / Revenue | — | 1.4% |
| Cash ConversionOCF / Net Profit | — | 3.65× |
| TTM Free Cash FlowTrailing 4 quarters | — | $14.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-29.7M | $1.7M | ||
| Q3 25 | $-52.9M | $2.3M | ||
| Q2 25 | — | $6.8M | ||
| Q1 25 | — | $6.2M | ||
| Q4 24 | $-46.3M | $2.1M | ||
| Q3 24 | — | $-1.3M | ||
| Q2 24 | — | $5.1M | ||
| Q1 24 | $-15.7M | $-277.0K |
| Q4 25 | — | $891.0K | ||
| Q3 25 | — | $1.9M | ||
| Q2 25 | — | $6.2M | ||
| Q1 25 | — | $5.9M | ||
| Q4 24 | — | $1.7M | ||
| Q3 24 | — | $-1.4M | ||
| Q2 24 | — | $5.1M | ||
| Q1 24 | — | $-326.0K |
| Q4 25 | — | 1.6% | ||
| Q3 25 | — | 3.2% | ||
| Q2 25 | — | 10.3% | ||
| Q1 25 | — | 10.3% | ||
| Q4 24 | — | 3.6% | ||
| Q3 24 | — | -3.0% | ||
| Q2 24 | — | 10.3% | ||
| Q1 24 | — | -0.7% |
| Q4 25 | — | 1.4% | ||
| Q3 25 | — | 0.7% | ||
| Q2 25 | — | 0.9% | ||
| Q1 25 | — | 0.6% | ||
| Q4 24 | — | 0.9% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.1% |
| Q4 25 | — | 3.65× | ||
| Q3 25 | — | 1.68× | ||
| Q2 25 | — | 0.06× | ||
| Q1 25 | — | 24.80× | ||
| Q4 24 | — | 0.28× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.06× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NUVB
Segment breakdown not available.
RGS
| Franchise Segment | $37.9M | 66% |
| Royalty | $13.6M | 24% |
| Other | $2.8M | 5% |
| Fees | $1.8M | 3% |
| Franchise Fees | $1.0M | 2% |
